selected publications
-
Anti-CD37 α-amanitin-conjugated antibodies as potential therapeutic weapons for Richter syndrome.
Blood.
2022
Academic Article
GET IT
Times cited: 11 -
Tumors carrying BRAF-mutations over-express NAMPT that is genetically amplified and possesses oncogenic properties.
Journal of translational medicine.
2022
Academic Article
GET IT
Times cited: 4 -
The Extracellular NADome Modulates Immune Responses.
Frontiers in immunology.
2021
Review
GET IT
Times cited: 20 -
NAMPT Over-Expression Recapitulates the BRAF Inhibitor Resistant Phenotype Plasticity in Melanoma.
Cancers.
2020
Academic Article
GET IT
Times cited: 17 -
Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-azacytidine.
Leukemia.
2011
Letter
GET IT
Times cited: 40 -
A PDGFRB-positive acute myeloid malignancy with a new t(5;12)(q33;p13.3) involving the ERC1 gene.
Leukemia.
2007
Letter
GET IT
Times cited: 20